LPL Financial’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15M | Buy |
558,342
+11,716
| +2% | +$108K | ﹤0.01% | 2276 |
|
|
2025
Q1 | $4.69M | Buy |
546,626
+452,723
| +482% | +$3.88M | ﹤0.01% | 2197 |
|
|
2024
Q4 | $1.01M | Buy |
93,903
+25,048
| +36% | +$269K | ﹤0.01% | 3446 |
|
|
2024
Q3 | $391K | Buy |
68,855
+15,550
| +29% | +$88.3K | ﹤0.01% | 4141 |
|
|
2024
Q2 | $225K | Sell |
53,305
-5,775
| -10% | -$24.4K | ﹤0.01% | 4388 |
|
|
2024
Q1 | $301K | Buy |
59,080
+200
| +0.3% | +$1.02K | ﹤0.01% | 4132 |
|
|
2023
Q4 | $548K | Buy |
58,880
+2,940
| +5% | +$27.4K | ﹤0.01% | 3548 |
|
|
2023
Q3 | $366K | Sell |
55,940
-4,965
| -8% | -$32.5K | ﹤0.01% | 3701 |
|
|
2023
Q2 | $495K | Buy |
60,905
+11,740
| +24% | +$95.4K | ﹤0.01% | 3426 |
|
|
2023
Q1 | $421K | Buy |
49,165
+5,525
| +13% | +$47.3K | ﹤0.01% | 3457 |
|
|
2022
Q4 | $404K | Buy |
43,640
+3,800
| +10% | +$35.2K | ﹤0.01% | 3422 |
|
|
2022
Q3 | $411K | Buy |
39,840
+2,410
| +6% | +$24.9K | ﹤0.01% | 3309 |
|
|
2022
Q2 | $375K | Buy |
37,430
+11,185
| +43% | +$112K | ﹤0.01% | 3423 |
|
|
2022
Q1 | $323K | Buy |
26,245
+10,250
| +64% | +$126K | ﹤0.01% | 3512 |
|
|
2021
Q4 | $277K | Sell |
15,995
-4,693
| -23% | -$81.3K | ﹤0.01% | 3725 |
|
|
2021
Q3 | $371K | Buy |
20,688
+8,913
| +76% | +$160K | ﹤0.01% | 3459 |
|
|
2021
Q2 | $269K | Buy |
+11,775
| New | +$269K | ﹤0.01% | 3654 |
|